glp-1 drugs and addiction medications get at the heart of addiction: study – WashU Medicine Not just obesity: GLP-1 receptor
Description
Although much of the supporting evidence comes from studies in animals, these results underscore their potential for clinical applications aimed at promoting healthy aging and reducing age-related cellular senescence
Rise of Dual and Triple Agonists: Beyond GLP-1, newer drugs target GIP and glucagon receptors for enhanced efficacy (e.g., Tirzepatide, Retatrutide)
10.2337/db13-0368 47 HardieD
If someone wants to request the data from this study, please contact the first author or corresponding author
